CADL
Candel Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Candel Therapeutics Inc is committed to developing innovative oncolytic therapies to treat various types of cancer.
Candel Therapeutics
CADL
Candel Therapeutics Inc is committed to developing innovative oncolytic therapies to treat various types of cancer.
Price history of Candel Therapeutics
Price history of Candel Therapeutics
Performance & Momentum
Strategic Analysis
Candel Therapeutics • 2026
Candel Therapeutics positions itself as an innovative player in the oncology biotechnology sector, focusing on the development of targeted oncolytic therapies. Its model relies on the use of modified viruses to specifically attack cancer cells, a niche with significant medical and commercial potential in immuno-oncology.
Strengths
- Specialization in a disruptive technology with high therapeutic potential
- Oncology portfolio addressing unmet medical needs
- Positioning in the U.S. sector, a driver of biotech innovations
Weaknesses
- Marked volatility in performance over several years
- Lack of recent major news limiting short-term visibility
Momentum
Current momentum is moderate with a recent downward trend, reflecting uncertainties related to clinical stages and valuation. Investors should remain vigilant, waiting for operational catalysts or clear announcements to confirm a reversal.
Similar stocks to Candel Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
